Delta9-tetrahydrocannabinol: A blunt weapon or a doubleedged sword for virus-induced neuroinflammation
Alison R. Van Zandt#, Miranda D. Horn#, Andrew G. MacLean*
Tulane National Biomedical Research Center, Tulane University, Covington, LA, USA (Van Zandt AR, Horn MD, MacLean AG)
Biomedical Sciences Training Program, Tulane University School of Medicine, New Orleans, LA, USA (Van Zandt AR, MacLean AG)
Department of Biological Sciences, Neuroscience Program, Ohio Wesleyan University, Delaware, OH, USA (Horn MD)
Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA (MacLean AG)
Tulane Brain Institute, New Orleans, LA, USA (Horn MD, MacLean AG)
Louisiana Cancer Research Center, New Orleans, LA, USA (MacLean AG)
Tulane Center for Aging, New Orleans, LA, USA (MacLean AG)
Online:2026-09-15
Published:2026-05-11
Contact:
Andrew G. MacLean, PhD, amaclean@tulane.edu.
Alison R. Van Zandt, Miranda D. Horn, Andrew G. MacLean. Delta9-tetrahydrocannabinol: A blunt weapon or a doubleedged sword for virus-induced neuroinflammation[J]. Neural Regeneration Research, 2026, 21(9): 4237-4238.